Form 8-K - Current report:
SEC Accession No. 0001564590-21-055072
Filing Date
2021-11-08
Accepted
2021-11-08 08:15:17
Documents
14
Period of Report
2021-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rdus-8k_20211108.htm   iXBRL 8-K 39378
2 EX-99.1 rdus-ex991_19.htm EX-99.1 730196
3 GRAPHIC gwpd2nwwzuvv000001.jpg GRAPHIC 3901
  Complete submission text file 0001564590-21-055072.txt   935278

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA rdus-20211108.xsd EX-101.SCH 5697
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE rdus-20211108_lab.xml EX-101.LAB 19330
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rdus-20211108_pre.xml EX-101.PRE 11495
7 EXTRACTED XBRL INSTANCE DOCUMENT rdus-8k_20211108_htm.xml XML 3546
Mailing Address ATTN: PRINCIPAL FINANCE OFFICER 22 BOSTON WHARF ROAD, 7TH FLOOR BOSTON MA 02210
Business Address ATTN: PRINCIPAL FINANCE OFFICER 22 BOSTON WHARF ROAD, 7TH FLOOR BOSTON MA 02210 617-551-4000
Radius Health, Inc. (Filer) CIK: 0001428522 (see all company filings)

EIN.: 800145732 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35726 | Film No.: 211386611
SIC: 2834 Pharmaceutical Preparations